Drawing for PROXIMA

USPTO serial 99587673

PROXIMA

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with PROXIMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alyssa M. Worsham

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and advisory services in the field of healthcare, pharmaceuticals and biomedicine; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analytics, IT asset management and analytics, security management and analytics, mobility management and analytics, service management and analytics, user workspace and desktop system management, customer relationship management, user permission and authorization management and supply chain managementACTIVE—
042Computer analysis of technical research data in the field of healthcare, pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software allowing to connect to databases containing pharmaceutical and medical information related to drug research and development; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information; providing temporary use of online non-downloadable computer software for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical drug research and development, clinical and post-market trials for drug research and development; statistical analysis and reporting for pharmaceutical and biomedical research enabled by artificial intelligence and machine learning for the purpose of drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analytics, IT asset management and analytics, security management and analytics, mobility management and analytics, service management and analytics, user workspace and desktop system management, customer relationship management, user permission and authorization management and supply chain managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 4, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2026DOCKASSIGNED TO EXAMINER—
Apr 29, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance